TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Aug 10, 4:05 PM ET

Grant Angus 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Aug 10, 2023

Insider Transaction Report

Form 4
Period: 2023-08-09
Grant Angus
EVP, Business Development
Transactions
  • Award

    Restricted Share Units

    2023-08-09+51,65251,652 total
    Ordinary Shares (51,652 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on August 9, 2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION